Harbour Investments’s Apellis Pharmaceuticals APLS Stock Holding History

Harbour Investments’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67	Closed	-$2.72K	–	4778
2026 Q1	$2.72K	Buy	+67	New	+$1.44K	﹤0.01%	3810
2024 Q4	–	Sell	-19	Closed	-$548	–	3490
2024 Q3	$548	Hold	19	–	–	﹤0.01%	3190
2024 Q2	$729	Sell	19 -19	-50%	-$860	﹤0.01%	3043
2024 Q1	$2.23K	Hold	38	–	–	﹤0.01%	2755
2023 Q4	$2.27K	Hold	38	–	–	﹤0.01%	2659
2023 Q3	$1.45K	Buy	+38	New	+$1.67K	﹤0.01%	2628

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments's APLS Position: Q2 2026 in Review

Harbour Investments sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 67 shares — an estimated $2.72K sold.

Harbour Investments first reported a position in APLS in Q3 2023 and held it in 6 quarters. The position peaked at $2.72K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Harbour Investments reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Harbour Investments sold 67 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
Harbour Investments first reported a position in Apellis Pharmaceuticals in Q3 2023 and held it in 6 quarters.
Harbour Investments's Apellis Pharmaceuticals position peaked at $2.72K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.